tetano
Editor, Senior Moderator
Paediatr Child Health. 2013 Mar;18(3):155-62.
The use of antiviral drugs for influenza: Guidance for practitioners, 2012/2013; Paediatric summary.
[Article in English, French]
Allen UD; Canadian Paediatric Society, Infectious Diseases and Immunization Committee.
Abstract
in English, French
This practice point summarizes the use of antiviral drugs to manage influenza illness in children and youth for the 2012/2013 season. It excerpts a recently published, full-length update of Canadian recommendations for clinicians on the use of antiviral drugs for the prevention and treatment of influenza, with a focus on paediatric antiviral therapy. Detailed information on the selective use of chemoprophylaxis can be found in the source document, which also highlights the importance of secondary bacterial infections (Streptococcus pneumoniae, methicillin-sensitive Staphylococcus aureus and methicillin-resistant S aureus) in cases of severe influenza illness.
KEYWORDS:
Antiviral therapy, Children, Influenza, Neuraminidase inhibitors
PMID:
24421680
[PubMed]
PMCID:
PMC3680290
[Available on 2014/3/1]
http://www.ncbi.nlm.nih.gov/pubmed/24421680
The use of antiviral drugs for influenza: Guidance for practitioners, 2012/2013; Paediatric summary.
[Article in English, French]
Allen UD; Canadian Paediatric Society, Infectious Diseases and Immunization Committee.
Abstract
in English, French
This practice point summarizes the use of antiviral drugs to manage influenza illness in children and youth for the 2012/2013 season. It excerpts a recently published, full-length update of Canadian recommendations for clinicians on the use of antiviral drugs for the prevention and treatment of influenza, with a focus on paediatric antiviral therapy. Detailed information on the selective use of chemoprophylaxis can be found in the source document, which also highlights the importance of secondary bacterial infections (Streptococcus pneumoniae, methicillin-sensitive Staphylococcus aureus and methicillin-resistant S aureus) in cases of severe influenza illness.
KEYWORDS:
Antiviral therapy, Children, Influenza, Neuraminidase inhibitors
PMID:
24421680
[PubMed]
PMCID:
PMC3680290
[Available on 2014/3/1]
http://www.ncbi.nlm.nih.gov/pubmed/24421680